Esra Yıldız Bölükbaşı

Esra Yıldız Bölükbaşı

Auto-generated profile, based on publicly available information

Esra Yıldız Bölükbaşı

Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2021 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
DMDanilo Bilches Medinas
Danilo Bilches Medinas
SMSajid Malik
Sajid Malik
EYEsra Yıldız‐Bölükbaşı
Esra Yıldız‐Bölükbaşı
JBJanina Borgonovo
Janina Borgonovo
MSMirva Saaranen
Mirva Saaranen
ATAslıhan Tolun
Aslıhan Tolun

25 January 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
EBEsra Yıldız Bölükbaşı
Esra Yıldız Bölükbaşı
JKJustyna Karolak
Justyna Karolak
Przemyslaw SzafranskiPrzemyslaw Szafranski
Przemyslaw Szafranski
TGTomasz Gambin
Tomasz Gambin
OMOmer Murik
Omer Murik
PSPawel Stankiewicz
Pawel Stankiewicz

1 May 2017 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
SMSara Mumtaz
Sara Mumtaz
EYEsra Yıldız
Esra Yıldız
KLKarmoon Lal
Karmoon Lal
ATAslıhan Tolun
Aslıhan Tolun
SMSajid Malik
Sajid Malik

20 September 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
EBEsra Yıldız Bölükbaşı
Esra Yıldız Bölükbaşı
JKJustyna Karolak
Justyna Karolak
Przemyslaw SzafranskiPrzemyslaw Szafranski
Przemyslaw Szafranski
TGTomasz Gambin
Tomasz Gambin
NWNicholas Willard
Nicholas Willard
PSPawel Stankiewicz
Pawel Stankiewicz
Background: Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) results from haploinsufficiency of the mesenchymal transcription factor FOXF1 gene. To date, only one case of an ACDMPV‐causative CNV deletion inherited from a very‐low level somatic mosaic mother has been reported.Methods: Clinical, histopathological, and molecular studies, including whole genome sequencing, chromosomal microarray analysis, qPCR, and Sanger sequencing, followed by in vitro fertilization (IVF) with preimplantation genetic testing (PGT) were used to study a family with a deceased neonate with ACDMPV.Results: A pathogenic CNV deletion of the lung‐specific FOXF1 enhancer in the proband was found to be inherited from an unaffected mother, 36% mosaic for this deletion in her peripheral blood cells. The qPCR analyses of saliva, buccal cells, urine, nail, and hair samples revealed 19%, 18%, 15%, 19%, and 27% variant allele fraction, respectively, indicating a high recurrence risk. Grandparental studies revealed that the deletion arose on the mother's paternal chromosome 16. PGT studies revealed 44% embryos with the deletion, reflecting high‐level germline mosaicism.Conclusion: Our data further demonstrate the importance of parental testing in ACDMPV families and reproductive usefulness of IVF with PGT in families with high‐level parental gonosomal mosaicism.

23 September 2026 in Pediatric Transplantation
Verified
Journal Article
Open access
PDF file
JKJustyna Karolak
Justyna Karolak
EMErnestina Melicoff
Ernestina Melicoff
NVNidhy Paulose Varghese
Nidhy Paulose Varghese
Przemyslaw SzafranskiPrzemyslaw Szafranski
Przemyslaw Szafranski
EBEsra Yıldız Bölükbaşı
Esra Yıldız Bölükbaşı
GMGeorge B. Mallory
George B. Mallory
Background: Pediatric‐onset pulmonary hypertension (PH) is a rare, progressive pulmonary vascular disease associated with high mortality. In cases unresponsive to pharmacological therapy with a severe cardiorespiratory phenotype, lung transplantation (LT) remains the final treatment option. Although LT for pediatric PH is considered a procedure with elevated risk, it has been successfully performed in this population. Case Presentation: A 3‐year‐old boy underwent uncomplicated LT for fulminant TBX4 ‐associated PH and developed hyperacute allograft failure requiring plasmapheresis, augmentation of immunosuppression, and the use of a monoclonal complement inhibitor. Despite extensive treatment the patient died 46 days after LT. Retrospective analysis of the serum sample taken at time of transplant prior to reperfusion was positive for six non‐histocompatibility antibodies: Sjogren syndrome antigen B, thyroglobulin, glutathione S‐transferase Theta‐1, colony stimulating factor 2, intracellular adhesion molecule 1, and interferon gamma that were not present in other pediatric thoracic transplant recipients. Conclusions: Hyperacute allograft rejection is extremely rare in LT recipients and its occurrence in this patient implies the need for further characterization of non‐HLA antibody‐associated LT rejection.